Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Cantor Fitzgerald
Cipla
Deloitte
Colorcon
Accenture
McKinsey
Healthtrust

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016097

« Back to Dashboard

NDA 016097 describes MINTEZOL, which is a drug marketed by Merck Sharp Dohme and is included in two NDAs. Additional details are available on the MINTEZOL profile page.

The generic ingredient in MINTEZOL is thiabendazole. There is one drug master file entry for this compound. Additional details are available on the thiabendazole profile page.
Summary for 016097
Tradename:MINTEZOL
Applicant:Merck Sharp Dohme
Ingredient:thiabendazole
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 016097

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength500MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cipla
Julphar
Mallinckrodt
Cantor Fitzgerald
Fuji
Medtronic
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.